Text Size
2278 studies found for:    "Bacterial Infections"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Terminated
Has Results 		A Study of Ceftobiprole in Patients With Fever and Neutropenia.
Conditions: Fever;   Neutropenia;   Gram-positive Bacterial Infections;   Pseudomonas Infection
Interventions: Drug: Ceftobiprole Medocaril;   Drug: Cefepime with or without vancomycin
22 Completed Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
Condition: Gram-negative Bacterial Infection
Interventions: Drug: AN3365;   Drug: Placebo
23 Completed Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Condition: Gram-Positive Bacterial Infections
Intervention: Drug: daptomycin
24 Completed An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults
Conditions: Bacterial Infections;   Staphylococcal Vaccines;   Immunotherapy, Active;   Staphylococcal Skin Infections;   Staphylococcal Infections
Interventions: Biological: SA3Ag vaccine;   Procedure: Blood draw;   Procedure: Colonization swab samples;   Biological: SA3Ag followed by Placebo;   Biological: Placebo;   Biological: SA3Ag with no booster in stage 2;   Procedure: Placebo with no booster in stage 2
25 Active, not recruiting Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years
Conditions: Staphylococcal Infections;   Staphylococcal Vaccines;   Bacterial Infections
Interventions: Biological: SA4Ag vaccine low dose;   Procedure: Blood draw;   Procedure: Colonization swab sample;   Biological: SA4Ag vaccine mid dose;   Biological: SA4Ag vaccine high dose;   Biological: SA3Ag vaccine;   Procedure: Blood sample;   Biological: Placebo;   Procedure: Colonization swab samples
26 Completed Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines
Conditions: Bacterial Infections;   Group B Streptococcus
Interventions: Biological: GBS III-TT-SSI;   Biological: GBS III-TT-MPHL
27 Completed PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)
Condition: Bacterial Infections
Intervention: Procedure: Procalcitonin guided strategy
28 Completed Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
Conditions: Gram-Positive Bacterial Infections;   Cross Infection
Intervention: Drug: Tigecycline
29 Completed Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit
Condition: Gram-Positive Bacterial Infections
Intervention: Drug: Piperacillin/tazobactam and other β-lactam/β-lactamase
30 Completed Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)
Conditions: Gram-Positive Bacterial Infections;   Staphylococcus Infections;   Vancomycin Resistance;   Methicillin Resistance
Intervention: Drug: Tigecycline
31 Completed Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
Condition: Gram-Negative Bacterial Infections
Intervention: Drug: tigecycline
32 Not yet recruiting Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
Condition: Gram-Negative Bacterial Infections
Interventions: Drug: Colistin;   Drug: Meropenem
33 Completed A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
Conditions: Urinary Tract Infections;   Bacterial Infections;   Bacteriuria;   Urologic Diseases
Intervention: Drug: Levofloxacin
34 Completed Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.
Condition: Bacterial Infections
Intervention: Drug: Tigecycline
35 Not yet recruiting Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Conditions: Bacterial Infections;   Obesity
Intervention: Drug: Clindamycin
36 Completed Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
Conditions: Bacterial Infections;   HIV Infections
Intervention: Drug: Azithromycin
37 Completed A Study of Azithromycin in HIV-Infected Patients
Conditions: Bacterial Infections;   HIV Infections
Intervention: Drug: Azithromycin
38 Completed Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
Conditions: Cystic Fibrosis;   Bacterial Infections
Intervention: Drug: mucoid exopolysaccharide P. aeruginosa immune globulin IV
39 Completed Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
Condition: Gram Positive Bacterial Infection
Intervention: Drug: Daptomycin
40 Completed
Has Results 		Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: ceftaroline;   Drug: vancomycin plus aztreonam;   Drug: Placebo
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years